The role of the kallikrein-kinin system in type I diabetes (insulitis)

Immunopharmacology. 1996 Jun;33(1-3):349-50. doi: 10.1016/0162-3109(96)00095-1.

Authors

A Zuccollo¹, F Cueva, M Frontera, M Navarro, O Catanzaro

Affiliation

¹ PROSIVAD-CONICET, Dept. of Physiology, Fac. Pharmacy and Biochemistry, Buenos Aires, Argentina.

PMID: 8856183
DOI: 10.1016/0162-3109(96)00095-1

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Bradykinin / analogs & derivatives
Bradykinin / pharmacology
Bradykinin Receptor Antagonists
Diabetes Mellitus, Experimental / etiology
Diabetes Mellitus, Experimental / physiopathology
Diabetes Mellitus, Type 1 / etiology
Diabetes Mellitus, Type 1 / physiopathology*
Kallikrein-Kinin System / drug effects
Kallikrein-Kinin System / physiology*
Male
Mice
Mice, Inbred C57BL
Receptor, Bradykinin B1
Receptor, Bradykinin B2
Receptors, Bradykinin / physiology

Substances

Bradykinin Receptor Antagonists
Receptor, Bradykinin B1
Receptor, Bradykinin B2
Receptors, Bradykinin
bradykinin, Leu(8)-des-Arg(9)-
icatibant
Bradykinin